Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q2 2026 Earnings

Apr 30Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.46

-0.81

-0.15

0.5

Details

Expected EPS

-0.869775

Actual EPS

-1.46

Surprise EPS

-0.59

Surprise Percent

-67.86%

Description

⁨Cartesian Therapeutics⁩ (⁦RNAC⁩) has reported earnings of ⁦-1.46⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.